Advertisement

ADVERTISEMENT

population health

Research in Review
Risk-Adapted Therapy Reduces Treatment Toxicity for Patients With Hodgkin Lymphoma
05/19/2017
JCP Editors
A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...
A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...
A...
05/19/2017
Journal of Clinical Pathways
Research in Review
Immune Checkpoint Inhibitors May Increase Response to CAR-T Therapy in ALL
05/19/2017
JCP Editors
Pembrolizumab improves response to chimeric antigen receptor (CAR) T-cell treatments in pediatric patients with B-cell relapsed acute lymphoblastic leukemia (ALL), according to research that will be presented at...
Pembrolizumab improves response to chimeric antigen receptor (CAR) T-cell treatments in pediatric patients with B-cell relapsed acute lymphoblastic leukemia (ALL), according to research that will be presented at...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
New Therapy May Effectively Treat Rare B-Cell Malignancy
05/18/2017
JCP Editors
A new treatment for a rare B-cell malignancy provided an objective response rate of 41% in a clinical trial, published in Blood (published online May 10, 2017; doi:10.1182/blood-2016-12-758383). ----- Related...
A new treatment for a rare B-cell malignancy provided an objective response rate of 41% in a clinical trial, published in Blood (published online May 10, 2017; doi:10.1182/blood-2016-12-758383). ----- Related...
A new...
05/18/2017
Journal of Clinical Pathways
Research in Review
Surveillance More Effective Than Surgery for Patients With Rectal Cancer After First-Line Care
05/09/2017
JCP Editors
Patients with rectal cancer who undergo first-line chemotherapy and radiation have lower risk of recurrence and higher rates of survival regardless of whether they choose to have surgery, according to a study...
Patients with rectal cancer who undergo first-line chemotherapy and radiation have lower risk of recurrence and higher rates of survival regardless of whether they choose to have surgery, according to a study...
...
05/09/2017
Journal of Clinical Pathways
Research in Review
Combination Therapy Effective in Treating Chemo-Resistant Ovarian Cancer
05/09/2017
JCP Editors
A combination regimen involving standard carboplatin chemotherapy and a novel drug may improve overall survival for more than 50% of women with high-grade serous ovarian cancers, according to research published in...
A combination regimen involving standard carboplatin chemotherapy and a novel drug may improve overall survival for more than 50% of women with high-grade serous ovarian cancers, according to research published in...
A...
05/09/2017
Journal of Clinical Pathways
Research in Review
Mutations in CLL Cells May Be Used as Biomarker for Future Relapse
05/09/2017
JCP Editors
Certain mutations in relapsed chronic lymphocytic leukemia (CLL) after targeted therapy have the potential to be used as a biomarker for relapse, according to research published in the Journal of Clinical Oncology...
Certain mutations in relapsed chronic lymphocytic leukemia (CLL) after targeted therapy have the potential to be used as a biomarker for relapse, according to research published in the Journal of Clinical Oncology...
...
05/09/2017
Journal of Clinical Pathways
Research in Review
New Biomarker Helps Predict PFS in Patients With Type of NSCLC
05/05/2017
JCP Editors
Patients with ALK-rearranged non-small cell lung cancer (NSCLC) who are treated with crizotinib may experience increased progression-free survival (PFS) with a decrease in a type of circulating tumor cells, according...
Patients with ALK-rearranged non-small cell lung cancer (NSCLC) who are treated with crizotinib may experience increased progression-free survival (PFS) with a decrease in a type of circulating tumor cells, according...
...
05/05/2017
Journal of Clinical Pathways
Research in Review
Treatment Better Than Observation for Older Patients With Esophageal Cancer
05/03/2017
JCP Editors
Patients aged 80 years or older with early-stage esophageal cancer who received treatment had an increased 5-year overall survival (OS) compared with those who received no treatment or observation alone,...
Patients aged 80 years or older with early-stage esophageal cancer who received treatment had an increased 5-year overall survival (OS) compared with those who received no treatment or observation alone,...
...
05/03/2017
Journal of Clinical Pathways
Research in Review
CAR T-Cells Offer Biomarker for Objective Response in Non-Hodgkin Lymphoma
04/28/2017
JCP Editors
The ability of chimeric antigen receptor (CAR) T-cells to perform multiple functions is associated with improved outcomes for patients with advanced non-Hodgkin lymphoma, offering a biomarker for response, according...
The ability of chimeric antigen receptor (CAR) T-cells to perform multiple functions is associated with improved outcomes for patients with advanced non-Hodgkin lymphoma, offering a biomarker for response, according...
The...
04/28/2017
Journal of Clinical Pathways
Research in Review
Serum Marker Helps Predict Response to CAR-T Therapy in Lymphoma
04/28/2017
JCP Editors
Patients with relapsed or refractory lymphoma who achieve durable remission after low-dose conditioning chemotherapy and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tend to have high serum levels of a...
Patients with relapsed or refractory lymphoma who achieve durable remission after low-dose conditioning chemotherapy and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tend to have high serum levels of a...
...
04/28/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
December 9 ⁠–⁠ December 11
AIBD logo
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use